Couverture média
67
Couverture média
Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres for treatment of liver tumors' Nom du média MENAFN -Press Releases (English) Pays/Territoire Jordan Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Morningstar.com Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Street Insider Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média PR Newswire Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres for treatment of liver tumors Nom du média BioSpace Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Yahoo! News Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Finanzen.net Pays/Territoire Germany Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Yahoo! Finance Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média ADVFN US Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Canadian Insider Pays/Territoire Canada Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média DenverGazette.com Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Canadian Life Sciences Database Pays/Territoire Switzerland Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média KOLD-TV Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Hawaii News Now Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WIBW Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Kgns.tv Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WAFB Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média 14 WFIE Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WDTV Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média KPLC TV Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média KWQC Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média KCBD Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WBKO Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média NewsChannel 10 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média KSLA Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média KEYC Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WBTV News Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WDAM-TV Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Fox 19 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WWNY TV 7 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WSAW Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média NBC 11 News Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média KWTX Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média KNOE TV8 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WMBF Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WALB 10 Pays/Territoire Georgia Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Wave 3 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WTOK-TV Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WCTV6 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média KOLO TV Reno Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WECT TV-6 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WLBT Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Fox 8 WVUE New Orleans Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WHSV Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WCJB Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média NBCNebraskaScottsbluff.com Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média My Sun Coast Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WFLX Fox 29 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WRDW Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WFMZ-TV Online Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WCAX TV3 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Webcenter 11 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WTVM Pays/Territoire Georgia Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média KLTV 7 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Kait 8 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média KFVS12 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Upper Michigans Source Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média KSNB Local4 Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média NBC12 Online Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média WOWT Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Live 5 WCSC Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Idaho State Journal Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Reflector.com Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média The Titusville Herald Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média DJournal.com Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Daily and Sunday Review Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham Titre ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors Nom du média Rocky Mount Telegram Pays/Territoire United States Date 4/19/22 Personnes Robert Joseph Abraham